Hydrogen peroxide-inducible clone 5 (Hic-5) as a potential therapeutic target for vascular and other disorders

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 7, 2012, Pages 601-609

  Kim Kaneyama, Joo ri ^a   Lei, Xiao Feng ^a   Arita, Shigeko ^a   Miyauchi, Aya ^a   Miyazaki, Takuro ^a   Miyazaki, Akira ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelial cell; Focal adhesion protein; Hic 5; Smooth muscle cell

Indexed keywords

4 [N (S GLUTATHIONYLACETYL)AMINO]PHENYLARSENOXIDE; ANTINEOPLASTIC AGENT; HYDROGEN PEROXIDE INDUCIBLE CLONE 5 PROTEIN; PAXILLIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELLULAR DISTRIBUTION; CYTOLOGY; ENDOTHELIUM CELL; HUMAN; MECHANICAL STRESS; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTINEOPLASTIC AGENTS; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM DOMAIN PROTEINS; MICE; NEOPLASMS; VASCULAR DISEASES;

EID: 84864519611     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.10736     Document Type: Review

References (30)

1. Hoffman BD, Grashoff C, Schwartz MA: Dynamic molecular processes mediate cellular mechanotransduction. Nature, 2011; 475: 316-323
2. Kim-Kaneyama JR, Takeda N, Sasai A, Miyazaki A, Sata M, Hirabayashi T, Shibanuma M, Yamada G, Nose K: Hic-5 deficiency enhances mechanosensitive apoptosis and modulates vascular remodeling. J Mol Cell Cardiol, 2011; 50: 77-86
3. Kim-Kaneyama JR, Suzuki W, Ichikawa K, Ohki T, Kohno Y, Sata M, Nose K, Shibanuma M: Uni-axial stretching regulates intracellular localization of Hic-5 expressed in smooth-muscle cells in vivo. J Cell Sci, 2005; 118: 937-949
4. Shibanuma M, Mashimo J, Kuroki T, Nose K: Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem, 1994; 269: 26767-26774
5. Turner CE: Paxillin and focal adhesion signalling. Nat Cell Biol, 2000; 2: E231-236
6. Matsuya M, Sasaki H, Aoto H, Mitaka T, Nagura K, Ohba T, Ishino M, Takahashi S, Suzuki R, Sasaki T: Cell adhesion kinase beta forms a complex with a new member, Hic-5, of proteins localized at focal adhesions. J Biol Chem, 1998; 273: 1003-1014
7. Thomas SM, Hagel M, Turner CE: Characterization of a focal adhesion protein, Hic-5, that shares extensive homology with paxillin. J Cell Sci, 1999; 112: 181-190
8. Nishiya N, Shirai T, Suzuki W, Nose K: Hic-5 interacts with GIT1 with a different binding mode from paxillin. J Biochem, 2002; 132: 279-289
9. Nishiya N, Iwabuchi Y, Shibanuma M, Cote J F, Tremblay ML, Nose K: Hic-5, a paxillin homologue, binds to the protein-tyrosine phosphatase PEST (PTP-PEST) through its LIM 3 domain. J Biol Chem, 1999; 274: 9847-9853
10. Shibanuma M, Kim-Kaneyama JR, Ishino K, Sakamoto N, Hishiki T, Yamaguchi K, Mori K, Mashimo J, Nose K: Hic-5 communicates between focal adhesions and the nucleus through oxidant-sensitive nuclear export signal. Mol Biol Cell, 2003; 14: 1158-1171
11. Kim-Kaneyama J, Shibanuma M, Nose K: Transcriptional activation of the c-fos gene by a LIM protein, Hic-5. Bio-chem Biophys Res Commun, 2002; 299: 360-365
12. Shibanuma M, Kim-Kaneyama JR, Sato S, Nose K: A LIM protein, Hic-5, functions as a potential coactivator for Sp1. J Cell Biochem, 2004; 91: 633-645
13. Yang L, Guerrero J, Hong H, DeFranco DB, Stallcup MR: Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol Biol Cell, 2000; 11: 2007-2018
14. Ghogomu SM, van Venrooy S, Ritthaler M, Wedlich D, Gradl D: HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription. J Biol Chem, 2006; 281: 1755-1764
15. Drori S, Girnun GD, Tou L, Szwaya JD, Mueller E, Xia K, Shivdasani RA, Spiegelman BM: Hic-5 regulates an epithelial program mediated by PPARgamma. Genes Dev, 2005; 19: 362-375
16. Heitzer MD, DeFranco DB: Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator. Mol Endocrinol, 2006; 20: 56-64
17. Fujita H, Kamiguchi K, Cho D, Shibanuma M, Morim-oto C, Tachibana K: Interaction of Hic-5, A senescence-related protein, with focal adhesion kinase. J Biol Chem, 1998; 273: 26516-26521
18. Deakin NO, Turner CE: Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Mol Biol Cell, 2011; 22: 327-341
19. Wu RF, Xu YC, Ma Z, Nwariaku FE, Sarosi GA Jr, Terada LS: Subcellular targeting of oxidants during endothelial cell migration. J Cell Biol, 2005; 171: 893-904
20. Tumbarello DA, Turner CE: Hic-5 contributes to epithe-lial-mesenchymal transformation through a RhoA/ ROCK-dependent pathway. J Cell Physiol, 2007; 211: 736-747
21. Kim-Kaneyama JR, Wachi N, Sata M, Enomoto S, Fuka-bori K, Koh K, Shibanuma M, Nose K: Hic-5, an adaptor protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo. Biochem Bio-phys Res Commun, 2008; 376: 682-687
22. Cadd VA, Hogg PJ, Harris AL, Feller SM: Molecular profiling of signalling proteins for effects induced by the anti-cancer compound GSAO with 400 antibodies. BMC Cancer, 2006; 6: 155
23. Dabiri G, Tumbarello DA, Turner CE, Van de Water L: Hic-5 promotes the hypertrophic scar myofibroblast phe-notype by regulating the TGF-beta1 autocrine loop. J Invest Dermatol, 2008; 128: 2518-2525
24. Dabiri G, Tumbarello DA, Turner CE, Van de Water L: TGF-beta1 slows the growth of pathogenic myofibro-blasts through a mechanism requiring the focal adhesion protein, Hic-5. J Invest Dermatol, 2008; 128: 280-291
25. Hornigold N, Craven RA, Keen JN, Johnson T, Banks RE, Mooney AF: Upregulation of Hic-5 in glomerulosclerosis and its regulation of mesangial cell apoptosis. Kidney Int, 2010; 77: 329-338
26. Inui S, Shono F, Noguchi F, Nakajima T, Hosokawa K, Itami S: In vitro and in vivo evidence of pathogenic roles of Hic-5/ARA55 in keloids through Smad pathway and profibrotic transcription. J Dermatol Sci, 2010; 58; 152-154
27. Aghajanova L, Velarde MC, Giudice LC: The progesterone receptor coactivator Hic-5 is involved in the patho-physiology of endometriosis. Endocrinology, 2009; 150: 3863-3870
28. Li X, Martinez-Ferrer M, Botta V, Uwamariya C, Banerjee J, Bhowmick NA: Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness. Oncogene, 2011; 30: 167-177
29. Caltagarone J, Hamilton RL, Murdoch G, Jing Z, DeFranco DB, Bowser R: Paxillin and hydrogen peroxide-inducible clone 5 expression and distribution in control and Alzheimer disease hippocampi. J Neuropathol Exp Neurol, 2010; 69: 356-371
30. Cukierman E, Pankov R, Stevens DR, Yamada KM: Taking cell-matrix adhesions to the third dimension. Science, 2001; 294: 1708-1712